(Total Views: 175)
Posted On: 01/17/2017 6:41:45 PM
Post# of 72446

"at this point we attribute the early favorable results to Brilacidin’s robust anti-inflammatory therapeutic profile."
We're not getting any statements like "possible anti-inflammatory action" any more. They are stating it as FACT.
What do you think this means for the Brilacidin-OM trial? I think it probably means very good things.
We're not getting any statements like "possible anti-inflammatory action" any more. They are stating it as FACT.
What do you think this means for the Brilacidin-OM trial? I think it probably means very good things.

